£6k to invest? These three growth champions are my top buys for 2020!

These growth champions dominate their respective markets and should continue to beat them for many years to come, argues Rupert Hargreaves.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When it comes to choosing companies for your retirement portfolio, I think it’s best to stick with high-quality growth stocks with robust track records of producing returns for investors alongside a durable competitive advantage — businesses like Dechra Pharmaceuticals (LSE: DPH). 

Unique business

Dechra is a relatively unique business. It is one of the world’s largest producers of veterinary medicines, a highly specialist but booming market. Over the past six years, the company’s sales have grown at a compound annual rate of 20%, while earnings per share have surged from just 18p in 2014 to an estimated 98p for 2020. The dividend to shareholders has more than doubled over the past six years. 

I think this trend is going to continue. People are willing to spend more and more on their pets, and they’re not willing to accept just any old pharmaceutical products. Vets and consumers want the highest quality products.

What’s more, Dechra’s products are protected by patents, and it is spending £25m every year in research and development to stay ahead of its competitors (R&D has increased in line with sales over the past five years). 

City analysts are expecting earnings growth of 64% in 2020 and 12% for 2021. The stock currently supports a dividend yield of 1.3%.

Explosive growth

JD Sports Fashion (LSE: JD) is another investment I think could help you build a million-pound pension pot. In my opinion, this is one of the best-run businesses on the market.

Sales have increased at a compound annual rate of 31% over the past five years and, during the past 10 years, the stock price has risen from around 10p to 746p at the time of writing, a compound annual return of 54%. 

JD Sports has been particularly successful in attracting young, wealthier consumers, and it’s just starting to expand in the United States. Last year, it bought the Finish Line shoe store chain for £400m in this market and the benefits are already starting to show through.

Net profit is expected to expand at a double-digit rate for the next two years and, considering the company’s growth track record, I reckon it’s highly likely growth won’t stop there. JD Sports seems to have cracked the code when it comes to sports/casualwear retailing. I reckon the firm can repeat the success it has had over the last decade in the next. 

Growing market

My last retirement millionaire-maker is the internet security business Avast (LSE: AVST). According to various sources, the size of the global internet security market is expected to hit around $250bn by the middle of the next decade. Avast is well-positioned to grab a significant share of this market as one of the primary providers of antivirus software for the personal and small business market.

This growth suggests that even if Avast doesn’t grow its market share, sales have the potential to expand at an annual rate of 10-11% for the foreseeable future. Because the company’s operating profit margins are nearly 40%, this growth should drop straight to the bottom line.

The stock might look expensive as it’s currently trading at a forward P/E of 17.8, although considering the market available to the company and the projected growth in demand for internet security software over the next five years, I think this is a price worth paying. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »

Investing Articles

After gaining over 200% in 12 months, what’s next for Nvidia stock?

Oliver thinks Nvidia stock could be as enduring an investment as Amazon. Even given the valuation risks, he says he…

Read more »